ASIAMONEY Japan deals of the year: M&A and Equity

14 Feb 2011

Each year we reveal the best capital markets transactions and investment banks in Japan. We begin with M&A and equity awards, where Astellas made a contentious takeover of OSI, Dai-Ichi's IPO made a splash, and Inpex's follow-on generated strong demand.

Best M&A

Astellas Pharma’s US$4.078 billion acquisition of OSI Pharmaceuticals
Advisers to Astellas: Citi
Advisers to OSI: Bank of America-Merrill Lynch; Lazard; Centerview Partners

The quest of Japanese companies for growth beyond a stagnant domestic economy with a rapidly ageing population is driving a boom in Japan cross-border M&A. Many potential ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access:

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: or find out more online here.